Atlas Trials

Study of Low Intensity Conditioning and Immunotherapy for High-Risk Cancers of the Blood

Clinical trial NCT00143884 · TERMINATED

Trial details

NCT number
NCT00143884
Sponsor
University of Michigan Rogel Cancer Center
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
LeukemiaLymphoma, Low-GradeLymphoma, Non-Hodgkin'sMultiple MyelomaMyelodysplastic Syndromes
Start date
2000-03-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.